ANIP vs HLT · rev $503.5M vs P/E 51, rev $6.28B
ANI Pharmaceuticals Inc (ANIP) versus Hilton Worldwide Holdings Inc (HLT) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported HLT revenue for 2026-06-30 was $6.28B. Net income was $867.0M. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
ANIP currently screens at market cap $1.41B. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
Not investment advice. Open the ANIP and HLT stock pages for the full models.
Not investment advice.